ARPO - Aerpio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
20,157
-
-
Operating Expense
17,647
22,438
31,332
21,389
29.492
Operating Income
-17,647
-22,438
-11,175
-21,389
-29.492
Net Non Operating Interest Income Expense
814.089
1,031
778.215
-105.782
-9.942
Other Income Expense
-
-1,863
-
93.719
-
Pretax Income
-18,696
-23,271
-10,397
-21,401
-39.434
Net Income Common Stockholders
-18,696
-23,271
-10,397
-22,344
-39.434
Diluted NI Available to Com Stockholders
-18,696
-23,271
-10,397
-22,344
-39.434
Basic EPS
-
-
0
-0.001
0
Diluted EPS
-
-
0
-0.001
0
Basic Average Shares
-
-
33,931
21,673
27,070
Diluted Average Shares
-
-
33,931
21,673
27,070
Total Operating Income as Reported
-19,718
-24,444
-11,181
-21,389
-29.492
Total Expenses
17,647
22,438
31,332
21,389
29.492
Net Income from Continuing & Discontinued Operation
-18,696
-23,271
-10,397
-21,401
-39.434
Normalized Income
-18,696
-21,407
-10,397
-21,494
-39.434
Interest Income
814.089
1,031
-
-
-
Interest Expense
-
-
-
-
9.942
Net Interest Income
814.089
1,031
778.215
-105.782
-9.942
EBIT
-17,647
-22,438
-11,175
-21,389
-29.492
EBITDA
-17,568
-
-
-
-
Reconciled Depreciation
78.613
76.501
46.686
51.268
-
Net Income from Continuing Operation Net Minority Interest
-18,696
-23,271
-10,397
-21,401
-39.434
Total Unusual Items Excluding Goodwill
-
-1,863
-
93.719
-
Total Unusual Items
-
-1,863
-
93.719
-
Normalized EBITDA
-17,568
-20,498
-11,128
-21,431
-29.492
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0